<page><tag>3</tag><title>Rigel, Merck Form Development Partnership</title><text> NEW YORK (Reuters) - Biotechnology company Rigel  Pharmaceuticals Inc. &amp;lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=RIGL.O target=/stocks/quickinfo/fullquote"&amp;gt;RIGL.O&amp;lt;/A&amp;gt; has entered into a collaboration  pact with drugmaker Merck   Co. Inc. &amp;lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=MRK.N target=/stocks/quickinfo/fullquote"&amp;gt;MRK.N&amp;lt;/A&amp;gt; to find treatments  for cancer and potentially other diseases, Rigel said on  Monday.</text></page>